Ulcerative colitis affects about 500,000 persons in the United States and accounts for more than 30,000 hospitalizations and 1 million workdays lost each year.1 The exacerbations and remissions that characterize the clinical course of the disease can make its management particularly challenging. What is the optimal approach to treatment? And which agents are most effective for maintenance therapy?
Sequencing of Pharmacological Management of Crohn's Disease and
New AGA guideline recommends blood and stool tests for monitoring
Ulcerative colitis: an update on management
Ulcerative colitis: Types, treatments, and more
In-Depth Reports - Ulcerative colitis - InDepth
Clinical review of ulcerative colitis: epidemiology, diagnosis and
Ulcerative colitis - The Lancet
Management of the hospitalized ulcerative colitis patient: A
Ulcerative colitis: management in adults, children and young
Advances in the treatment of Crohn's disease and ulcerative
3 Key Difference Between Crohn's Disease and Ulcerative Colitis
